Bristol Myers deploys Claude to 30,000

Bristol Myers Squibb and KPMG used the same week to announce large-scale Anthropic deployments, extending Claude from pilot use into broad employee and client-facing workflows. Bristol Myers said on May 20 that it would make Claude available to more than 30,000 employees as part of a strategic agreement with Anthropic. KPMG said on May 19 that it was integrating Claude across its business and giving access to more than 276,000 employees in 138 countries and territories. The announcements add two large enterprise names to Anthropic’s push to sell Claude as a company-wide platform rather than a narrow chatbot tool. ### Where is Bristol Myers actually putting Claude? Bristol Myers Squibb said the deployment will span research, clinical development, manufacturing, commercial and corporate functions. The company said the agreement is intended to position Claude Enterprise as a “shared intelligence platform” across its global operations. (news.bms.com) The Princeton, New Jersey-based drugmaker said the goal is to accelerate the discovery, development and delivery of medicines. Reuters reported that Bristol Myers described the rollout as a way to speed drug discovery by making Claude available to more than 30,000 employees. (news.bms.com) ### Why is a drugmaker using this beyond research? Bristol Myers said the planned use goes beyond conversational AI and includes Claude’s “agentic capabilities” to connect people, systems and institutional knowledge at enterprise scale. The company’s statement tied the rollout not only to science teams but also to manufacturing, regulatory and commercial workstreams. (msn.com) MobiHealthNews reported that Bristol Myers said Claude would assist with drug discovery, clinical development, regulatory submissions, manufacturing operations and commercial workflows. That scope suggests the company is treating the model as internal operating software across multiple functions, according to its announcement. (news.bms.com) ### What exactly did KPMG announce two days earlier? KPMG said on May 19 that it had formed a global alliance with Anthropic and launched “KPMG Digital Gateway Powered by Claude.” The company said Claude would be embedded in the software its people and clients use for work, starting with new tools for tax and legal clients. (mobihealthnews.com) Anthropic said every one of KPMG’s 276,000-plus employees globally will gain access to Claude. KPMG said the firm operates across 138 countries and territories, and that Anthropic had named KPMG a preferred partner for private equity work. ### How do the two rollouts differ? Bristol Myers framed its deal around internal deployment across a pharmaceutical company’s operations, with emphasis on drug discovery and medicine development. (kpmg.com) KPMG framed its alliance around both internal workforce access and client delivery through Digital Gateway, with an initial focus on tax, legal and private equity use cases. (anthropic.com) The employee counts also differ in scale. Bristol Myers said Claude would be made available to more than 30,000 employees, while KPMG said access would extend to more than 276,000 employees worldwide. ### What happens next in each rollout? (news.bms.com) Bristol Myers said the rollout begins this year across its global operations under the new agreement with Anthropic. KPMG said its first client-facing deployments are starting with tax and legal capabilities inside Digital Gateway, and the companies also said they plan to build new Claude-powered products for private-equity portfolio companies. (news.bms.com)